These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1168258)

  • 1. Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. 1. Syntheses and stereochemical and structural requirements for activity of butaclamol and related compounds.
    Bruderlein FT; Humber LG
    J Med Chem; 1975 Feb; 18(2):185-8. PubMed ID: 1168258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. A hypothesis on their mode of interaction with the central dopamine receptor.
    Humber LG; Bruderlein FT; Voith K
    Mol Pharmacol; 1975 Nov; 11(6):833-40. PubMed ID: 1239657
    [No Abstract]   [Full Text] [Related]  

  • 3. The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug.
    Voith K; Herr F
    Psychopharmacologia; 1975 Apr; 42(1):11-20. PubMed ID: 1171496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of enantiomeric purity on solubility determination of dexclamol hydrochloride.
    Liu ST; Hurwitz A
    J Pharm Sci; 1978 May; 67(5):636-8. PubMed ID: 641798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and neuroleptic activity of isomeric thieno(1,4)benzothiazines.
    Grol CJ; Rollema H
    J Med Chem; 1975 Aug; 18(8):857-61. PubMed ID: 1171985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptics related to butaclamol. Synthesis and some psychopharmacological effects of a series of 3-aryl analogues.
    Voith K; Bruderlein FT; Humber LG
    J Med Chem; 1978 Jul; 21(7):694-8. PubMed ID: 27637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The noradrenergic cyclic AMP generating system in the rat limbic forebrain and its stereospecificity for butaclamol.
    Robinson SE; Sulser F
    J Pharm Pharmacol; 1976 Aug; 28(8):645-6. PubMed ID: 11316
    [No Abstract]   [Full Text] [Related]  

  • 8. Analogs of phenothiazines. 6. Stereochemical assignment of isomeric aminoalkylidene derivatives of xanthenes and thioxanthenes with neuropharmacological activity.
    Kaiser C; Warren RJ; Zirkle CL
    J Med Chem; 1974 Jan; 17(1):131-3. PubMed ID: 4808461
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroleptics related to butaclamol. An investigation of the effects of chlorine substituents on the aromatic rings.
    Humber LG; Sideridis N; Asselin AA; Bruderlein FT; Voith K
    J Med Chem; 1978 Dec; 21(12):1225-31. PubMed ID: 31480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic activity of chiral trans-hexahydro-gamma-carbolines.
    Sarges R; Howard HR; Donahue KM; Welch WM; Dominy BW; Weissman A; Koe BK; Bordner J
    J Med Chem; 1986 Jan; 29(1):8-19. PubMed ID: 3941416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the dopamine receptor. 2. Features derived from modifications in the rings A/B region of the neuroleptic butaclamol.
    Philipp AH; Humber LG; Voith K
    J Med Chem; 1979 Jul; 22(7):768-73. PubMed ID: 571917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and X-ray data of novel potential antipsychotic agents. Substituted 7-phenylquinolizidines: stereospecific, neuroleptic, and antinociceptive properties.
    Imhof R; Kyburz E; Daly JJ
    J Med Chem; 1984 Feb; 27(2):165-75. PubMed ID: 6198519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agents acting on the central nervous system. 15. 2-Substituted 1,2,3,4,6,7,12,12a-octahydropyrazino(2',1':6,1)pyrido(3,4-b)indoles. A new class of central nervous system depressants.
    Saxena AK; Jain PC; Anand N
    J Med Chem; 1973 May; 16(5):560-4. PubMed ID: 4718475
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral studies on the enantiomers of butaclamol demonstrating absolute optical specificity for neuroleptic activity.
    Voith K; Cummings JR
    Can J Physiol Pharmacol; 1976 Aug; 54(4):551-60. PubMed ID: 10059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of butaclamol, a new neuroleptic, on serotoninergic mechanisms.
    Pugsley TA; Lippmann W
    J Pharm Pharmacol; 1977 Mar; 29(3):135-8. PubMed ID: 15075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rating the behavioral effects of amphetamine.
    Ellinwood EH; Balster RL
    Eur J Pharmacol; 1974 Sep; 28(1):35-41. PubMed ID: 4473346
    [No Abstract]   [Full Text] [Related]  

  • 17. [Farnesol and neuroleptics. II. Action of farnesol, alone or associated with a neuroleptic, on the stereotypies induced in the rat by amphetamine].
    Binet P; Miocque M; Roux M; Rinjard P
    Ann Pharm Fr; 1975; 33(6-7):321-8. PubMed ID: 1241259
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis of 2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole derivatives and their central nervous system activities.
    Nagai Y; Irie A; Masuda Y; Oka M; Uno H
    J Med Chem; 1979 Jun; 22(6):677-83. PubMed ID: 37336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM
    Arzneimittelforschung; 1967 Jul; 17(7):841-54. PubMed ID: 5632842
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
    Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
    Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.